SARS-CoV-2 can cause strong mucosal immunity to induce sIgA production, and the serum SARS-CoV-2-specific IgA level was found to have a significant positive association with the APACHE-II score of critically ill patients with COVID-19 (14). The gene discussed is CD79A; the disease is COVID-19.